Adverse effect monitoring: Opportunity for patient care and pharmacy practice

Journal of the American Pharmacists Association

Volumn 44, Issue 1, 2004, Pages 75-88

  Hermansen Kobulnicky, Carol J ^a   Wiederholt, Joseph B ^b   Chewning, Betty ^b  

^a UNIVERSITY OF WYOMING   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Adverse drug effects; Chemotherapy treatment; Monitoring tools; Pharmacist patient relationship; Shared decision making; Symptom management

Indexed keywords

ANTINEOPLASTIC AGENT;

AMBULATORY CARE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MONITORING; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; MALE; METHODOLOGY; NEOPLASM; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; STANDARD;

AMBULATORY CARE; ANTINEOPLASTIC AGENTS; DRUG MONITORING; FEMALE; HUMANS; MALE; NEOPLASMS; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; QUESTIONNAIRES; SELF ADMINISTRATION;

EID: 1442308367     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/154434504322713264     Document Type: Article

References (29)

1. McDonough RP. Finding drug therapy problems. J Am Pharm Assoc. 1999;39:568, 570.
2. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill Health Professions Division; 1998.
3. Chewning B, Sleath B. Medication decision-making and management: a client-centered model. Soc Sci Med. 1996;42:389-98.
4. Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender, and patient question asking behavior with the content of pharmacist-patient communication. Pharm Res. 1997;14:145-51.
5. Chewning B, Boh L, Wiederholt J, et al. Does the concordance concept serve patient medication management? Int J Pharm Prac. 2001;9:71-9.
6. Cohen JS. Ways to minimize adverse drug reactions. Individualized doses and common sense are key. Postgrad Med. 2000;106:163-8,171-2.
7. Wiederholt JB, Wiederholt PA. The patient: our teacher and friend. Am J Pharm Educ. 1997;61:415-23.
8. McGrath JM. Physicians' perspectives on communicating prescription drug information. Qual Health Res. 1999;9:731-45.
9. U.S. Department of Health and Human Services. Healthy people 2010: understanding and improving health. 2nd ed. Washington, D.C.: U.S. Government Printing Office; 2000.
10. Prescription drug advertising: issues and perspectives [transcript]. New York, N.Y.:CBS Television; 1984.
11. Chewning B. Clients' side effect expectations, experience, and discontinuation of oral contraceptives. Communicating risk to patients [proceedings]. Reston, Va.: U.S. Pharmacopeial Convention; 1994.
12. Chewning B. Communicating side effect information to patients: a test of effects. 9th International Social Pharmacy Workshop Proceedings. Madison, Wisconsin; 1996.
13. Chewning B, Mosena P, Wilson D, Erdman H, et al. Evaluation of a computerized contraceptive decision aid for adolescent patients. Patient Educ Couns. 1999;38:227-39.
14. Ziegler DK, Mosier MC, Buenaver M, Okuyemi K. How much information about adverse effects of medication do patients want from physicians? Arch Intern Med. 2001;161:706-13.
15. Berry DC, Knapp P, Raynor DK. Provision of information about drug side-effects to patients. Lancet. 2002;359:853-4.
16. Burman M. Health diaries in nursing research and practice. Image J Nurs Sch. 1995;27:147-52.
17. Fayers P. MRC quality of life studies using a daily diary card - practical lessons learned from cancer trials. Qual Life Res. 1995;4:343-52.
18. Mullin SM, Fletcher DM, Tyler LS. Mail-in questionnaire for monitoring nausea and vomiting in oncology outpatients. Am J Health Syst Pharm. 1998;55:1903-6.
19. Leventhal H, Leventhal E, Schaefer P. Vigilant coping and health behavior. In: Ory M, Abeles R, eds. Aging, health, and behavior. Baltimore, Md.: Johns Hopkins; 1991:109-40.
20. Leventhal H, Nerenz DR, Straus A. Self-regulation and the mechanisms for symptom appraisal. In: Psychosocial epidemiology 3: symptoms, illness behavior, and help-seeking. New York, N.Y.: Neale Watson; 1980:55-86.
21. Johnson JE. Self-regulation theory and coping with physical illness. Res Nurs Health. 1999;22:435-48.
22. Leventhal H, Johnson JE. Laboratory and field experimentation: development of a theory of self-regulation. In: Wooldridge PJ, Schmitt MH, Skipper JK, Leonard RC, eds. Behavioral science and nursing theory. St. Louis, Mo.: The C.V. Mosby Company; 1983:189-262.
23. Baumann LJ, Leventhal H. I can tell when my blood pressure is up, can't I? Health Psychol. 1985;4:203-18.
24. The WriteTrack: personal health tracker. Princeton, N.J.: Doctors+Designers; 1997.
25. Hermansen-Kobulnicky CJ. Teaching patients to monitor chemotherapy side effects: impact on participation with providers and functional adaptation [dissertation]. Madison, Wisc.: University of Wisconsin-Madison; 2002.
26. Glanz K, Lewis FM, Rimer BK, eds. Health behavior and health education. San Francisco, Calif.: Jossey-Bass Publishers; 1997.
27. Bislew HD, Sorensen TD. Use of focus groups as a tool to enhance a pharmaceutical care practice. J Am Pharm Assoc. 2003;43:424-34.
28. Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer. 1995;76:167-77.
29. Cassileth BR, Zupkis RV, Sutton-Smith K, March V. Information and participation preferences among cancer patients. Ann Intern Med. 1980;92:832-6.